Blog

- Uncategorized

Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval

ST. LOUIS, Oct. 9, 2025 /PRNewswire/ — Amplifi Vascular, developer of the first-of-its-kind Vein Dilation System designed to increase eligibility, improve creation and early maturation of arteriovenous fistulas (AVFs) for hemodialysis, today announced three major milestones: positive first-in-human (FIH) study results, the close of a $6.9 million Series A financing, and U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE).

Read More »

New method may detect infectious tuberculosis in the air

Researchers at Karolinska Institutet, in collaboration with colleagues in South Africa, have investigated whether tuberculosis can be traced in exhaled air. The results, published in Open Forum Infectious Diseases, show that a new method may help identify people with infectious tuberculosis directly in primary care.

Read More »